One2Treat

Patients

Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, discusses the pressing need for quantitative methodologies.

News

LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.